3.430USD-1.01%Mkt Cap: 615.00M USDP/E: —Last update: 2026-06-01
Prime Medicine, Inc., a biotechnology company, engages in delivering genetic medicines to address the spectrum of diseases by deploying gene editing technology in the United States. Its lead therapeutic product candidate…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap615.00M USD
Enterprise Value620.21M USD
Revenue (TTM)4.03M USD
Gross Profit-150.14M USD
Net Income (TTM)-201.14M USD
Revenue/Share0.0250 USD
Last Price3.430 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees146
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.07
PEG—
EV/EBITDA-3.12
EV/Revenue153.74
P/S158.95
P/B8.35
EPS (TTM)-1.23
EPS (Forward)-0.87
52W Range
1.18039% of range6.940
52W High6.940 USD
52W Low1.180 USD
Profitability
Gross Margin0.00%
Oper. Margin-5917.52%
EBITDA Margin0.00%
Profit Margin-4342.44%
ROE-166.41%
ROA-58.69%
Growth
Revenue Growth-41.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-162.56M USD
CapEx (TTM)4.53M USD
FCF Margin-1941.44%
FCF Yield-12.73%
Net Debt-20.98M USD
Net Debt/EBITDA0.11
Balance Sheet
Debt/Equity0.96
Current Ratio3.80
Quick Ratio3.73
Book Value/Sh0.4250 USD
Cash/Share0.7500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)6.917 USD
Target Range4.250 USD – 11.00 USD
# Analysts9
Ownership
Shares Out.180.62M
Float108.73M
Insiders23.76%
Institutions66.50%
Short Interest
Short Ratio14.3d
Short % Float21.63%
Short % Out.16.90%
Shares Short30.53M
Short (prev mo.)30.24M
Technical
SMA 503.422 (+0.2%)
SMA 2003.977 (-13.8%)
Beta2.36
S&P 52W Chg27.70%
Avg Vol (30d)2.25M
Avg Vol (10d)2.70M
Technical Indicators
RSI (14)56.9
MACD-0.0765
MACD Signal-0.1382
MACD Hist.+0.0617
BB Upper3.653 USD
BB Middle3.165 USD
BB Lower2.676 USD
BB Width30.88%
ATR (14)0.2486 USD
Vol Ratio (20d)0.91x